Related references
Note: Only part of the references are listed.Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics
Claudio G. Brunstein et al.
BLOOD (2011)
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation
Mauro Di Ianni et al.
BLOOD (2011)
Granzyme B is not required for regulatory T cell-mediated suppression of graft-versus-host disease
Sheng F. Cai et al.
BLOOD (2010)
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation.
Ted A. Gooley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
FOXP3+ regulatory T cells in the human immune system
Shimon Sakaguchi et al.
NATURE REVIEWS IMMUNOLOGY (2010)
CD44 expression positively correlates with Foxp3 expression and suppressive function of CD4+ Treg cells
Tie Liu et al.
BIOLOGY DIRECT (2009)
Quantitative DNA Methylation Analysis of FOXP3 as a New Method for Counting Regulatory T Cells in Peripheral Blood and Solid Tissue
Georg Wieczorek et al.
CANCER RESEARCH (2009)
Mechanisms of Foxp3+ T Regulatory Cell-Mediated Suppression
Ethan M. Shevach
IMMUNITY (2009)
Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage?
Jochen Huehn et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Cell cycle and immune-related processes are significantly altered in chronic GVHD
S. J. Oh et al.
BONE MARROW TRANSPLANTATION (2008)
Gene-expression profiles of peripheral blood mononuclear cell subpopulations in acute graft-vs-host disease following cord blood transplantation
Naoyuki Takahashi et al.
EXPERIMENTAL HEMATOLOGY (2008)
Microfluidic-based enzymatic on-chip labeling of miRNAs
Sonia Vorwerk et al.
NEW BIOTECHNOLOGY (2008)
Therapeutic effect of CXCR3-expressing regulatory T cells on liver, lung and intestinal damages in a murine acute GVHD model
H. Hasegawa et al.
GENE THERAPY (2008)
Reconstitution of FOXP3+ regulatory T cells (Tregs) after CD25-depleted allotransplantion in elderly patients and association with acute graft-versus-host disease
Stephan Mielke et al.
BLOOD (2007)
Cutting edge:: High molecular weight hyaluronan promotes the suppressive effects of CD4+CD25+ regulatory T cells
Paul L. Bollyky et al.
JOURNAL OF IMMUNOLOGY (2007)
High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT
Katayoun Rezvani et al.
BLOOD (2006)
Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD
K Rieger et al.
BLOOD (2006)
Suppressor activity and potency among regulatory T cells is discriminated by functionally active CD44
M Firan et al.
BLOOD (2006)
Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease
CA Wysocki et al.
BLOOD (2005)
Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease
E Zorn et al.
BLOOD (2005)
Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome
C Schmid et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
CCR6 regulates CD4+ T-cell-mediated acute graft-versus-host disease responses
R Varona et al.
BLOOD (2005)
Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self
S Sakaguchi
NATURE IMMUNOLOGY (2005)
Increased gene expression of chemokine receptors is correlated with acute graft-versus-host disease after allogeneic stem cell transplantation
M Jaksch et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD
J Ermann et al.
BLOOD (2005)
An absence of CCR5 on donor cells results in acceleration of acute graft-vs-host disease
LA Welniak et al.
EXPERIMENTAL HEMATOLOGY (2004)
Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells
J Huehn et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Recipient CD4+ T cells that survive irradiation regulate chronic graft-versus-host disease
BE Anderson et al.
BLOOD (2004)
Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning
CA Wysocki et al.
JOURNAL OF IMMUNOLOGY (2004)
L-Selectinhi but not the L-selectinlo CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection
PA Taylor et al.
BLOOD (2004)
Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells
WJ Grossman et al.
BLOOD (2004)
Amelioration of graft versus host disease by galectin-1
LG Baum et al.
CLINICAL IMMUNOLOGY (2003)
Role of CXCR3-induced donor T-cell migration in acute GVHD
U Duffner et al.
EXPERIMENTAL HEMATOLOGY (2003)
Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays
T Ichiba et al.
BLOOD (2003)
The intracellular granzyme B inhibitor, proteinase inhibitor 9, is up-regulated during accessory cell maturation and effector cell degranulation, and its overexpression enhances CTL potency
CE Hirst et al.
JOURNAL OF IMMUNOLOGY (2003)
CD4+CD25+ immunoregulatory T cells:: New therapeutics for graft-versus-host disease
JL Cohen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Donor-type CD4+CD25+ regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation
P Hoffmann et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response?
GA Rabinovich et al.
TRENDS IN IMMUNOLOGY (2002)
The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethality
PA Taylor et al.
BLOOD (2002)
Share Paper
